| Literature DB >> 25722896 |
Patricia Roccon Bianchi1, Vera Cavalcanti de Araujo1, José Wagner Banterli Ribeiro1, Fabricio Passador-Santos1, Ney Soares de Araujo1, Andresa Borges Soares1.
Abstract
Congenital granular cell epulis is a rare benign soft tissue lesion arising from the alveolar ridge in neonates. A rare case of multiple congenital granular cell epulis is reported, alongside a description of its vascular immunohistochemical profile. A female newborn presented with two exophytic pedunculated red nodules located on the alveolar ridge between the future eruption sites of the incisors and canines of the mandible and maxilla. A conservative surgical excision was performed on the second day of life. Histology revealed proliferation of round granular cells containing an abundant eosinophilic cytoplasm with basophilic nuclei, ranging from round to oval in shape. Numerous blood vessels were also seen. Immunohistochemical analysis of the granular cells revealed positivity for CD68, D2-40, Ki67, VEGF, and FGF and negativity for S100, CD34, and CD105. Immunostaining for CD34, CD105, and D2-40 confirmed the presence of a large number of blood and lymphatic vessels. Although rare, an understanding of this lesion is paramount for correct diagnosis and appropriate treatment. In the present report, the immunohistochemical profile confirmed increased vascularization, proving that these lesions are composed of not only new and preexisting blood vessels, but also lymphatic vessels.Entities:
Year: 2015 PMID: 25722896 PMCID: PMC4334617 DOI: 10.1155/2015/878192
Source DB: PubMed Journal: Case Rep Dent
Figure 1Clinical and macroscopic features. (a) Two pedunculated reddish nodules located in the mandible and maxilla. ((b) and (c)) The lesions following surgical excision.
Figure 2Histological and immunohistochemical sections. (a) Large round granular cells with an abundant eosinophilic cytoplasm and basophilic nuclei in a background of prominent vasculature and lined by an atrophic epithelium (H&E 200x). (b) Granular cells demonstrating strong positivity for CD68 (400x). ((c) and (d)) Endothelial cells positive for CD105 and CD34, respectively. (e) D2-40 positive immunostaining for granular cells and lymphatic vessels. (f) Weak staining for Ki67, showing a low grade of proliferation. ((g) and (h)) Overexpression of VEGF and FGF in granular cells and endothelial cells, respectively.
Details of the antibodies used for immunohistochemistry.
| Specificity | Clone | Dilution | Source | Buffer (AR) |
|---|---|---|---|---|
| CD68 | M0814 | 1 : 500 | Dako* | Citrate |
| S-100 | Z0311 | 1 : 1200 | Dako* | — |
| CD34 | QBEnd 10 | 1 : 50 | Dako* | Citrate |
| CD 105 | SNG | 1 : 10 | Dako* | Pepsin |
| D2-40 | D2-40 | 1 : 200 | Dako* | Tris-EDTA |
| FGF II | Sc-79 | 1 : 100 | Santa Cruz** | Citrate |
| VEGF | Sc-7269 | 1 : 100 | Santa Cruz** | Citrate |
| Ki-67 | MIB-1 | 1 : 400 | Dako* | Citrate |
∗ is: Dako Corporation, Glostrup, Denmark.
∗∗ is: Santa Cruz Biotechnogy, Inc., Santa Cruz, CA, USA.